LSVAX
Price
$19.89
Change
+$0.05 (+0.25%)
Updated
Jul 31 closing price
Net Assets
355.39M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

LSVAX vs VSCIX

LSVAX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
LSVAX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSVAX is a StrongBuy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. LSVAX (355M). VSCIX pays higher dividends than LSVAX: VSCIX (1.23) vs LSVAX (0.68). LSVAX was incepted earlier than VSCIX: LSVAX (29 years) vs VSCIX (29 years). LSVAX (1.46) is less costly to investors than VSCIX (0.03). LSVAX is a more actively managed with annual turnover of: 36.00 vs. VSCIX (17.00). LSVAX has a lower initial minimum investment than VSCIX: LSVAX (0) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. LSVAX (4.08). VSCIX return over 5 years is better than : 35.13 vs. LSVAX (-31.42).
LSVAXVSCIXLSVAX / VSCIX
Total Expense Ratio1.400.034,667%
Annual Report Gross Expense Ratio1.460.034,867%
Fund Existence29 years29 years-
Gain YTD20.25414.591139%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets355M189B0%
Annual Yield % from dividends0.681.2355%
Returns for 1 year4.0822.5818%
Returns for 3 years-12.8143.44-29%
Returns for 5 years-31.4235.13-89%
Returns for 10 years-36.38156.07-23%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C